Table 4.

Effects of single-pill amlodipine/atorvastatin-based therapy on renal and vascular functions.

	Baseline	Week 16
Renal function
Serum creatinine (mg/dL)	1.04 ± 0.44	1.09 ± 0.50
eGFR (mL/min/1.73 m2)	60.4 ± 25.7	58.8 ± 25.6
UACR (mg/g-Cr)	1034 ± 1480	733 ± 1218*
Serum cystatin C (mg/L)	1.30 ± 0.45	1.31 ± 0.49
Vascular function
baPWV (cm/s)	1903 ± 353	1786 ± 382*
AI (%)	84 ± 15	81 ± 14
cSBP (mmHg)	148 ± 19	129 ± 23**

Values are means ± SD. eGFR: estimated glomerular filtration rate; UACR: urine albumin-to-creatinine ratio; baPWV: brachial-ankle pulse wave velocity; AI: augmentation index; cSBP: central systolic blood pressure.

*P < 0.05, **P < 0.01.